Equine papillomavirus type 1: complete nucleotide sequence and characterization of recombinant virus-like particles composed of the EcPV-1 L1 major capsid protein
- PMID: 15485669
- DOI: 10.1016/j.bbrc.2004.09.154
Equine papillomavirus type 1: complete nucleotide sequence and characterization of recombinant virus-like particles composed of the EcPV-1 L1 major capsid protein
Abstract
Equus caballus papillomavirus type 1 (EcPV-1) was isolated from a cutaneous papilloma, the most common neoplasm in horses. The complete EcPV-1 nucleotide sequence and genomic organization were determined. Phylogenetic analysis showed that EcPV-1 is a close-to-root papillomavirus, with only distant relationships to the fibropapillomaviruses and the benign cutaneous papillomaviruses. To produce EcPV-1 virus-like particles (VLPs), the EcPV-1 L1 major capsid protein was expressed in insect cells using a recombinant baculovirus vector. The self-assembled EcPV-1 VLPs were morphologically indistinguishable from wild type papillomavirus virions. Monoclonal antibodies were developed against intact and denatured EcPV-1 VLPs. When tested by ELISA, all monoclonal antibodies produced against intact (#18) and some against denatured EcPV-1 VLPs (#16) reacted with intact EcPV-1 VLPs only, demonstrating that the VLPs carry type-specific conformational as well as linear epitopes on their surface. Recombinant EcPV-1 VLPs offer the potential of a noninfectious vaccine to prevent and eradicate equine cutaneous papillomatosis.
Similar articles
-
Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination.Gynecol Oncol. 1994 Oct;55(1):13-20. doi: 10.1006/gyno.1994.1239. Gynecol Oncol. 1994. PMID: 7525426
-
Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.Enzyme Microb Technol. 2012 Mar 10;50(3):173-80. doi: 10.1016/j.enzmictec.2011.11.004. Epub 2011 Nov 25. Enzyme Microb Technol. 2012. PMID: 22305172
-
Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae.Protein Expr Purif. 1999 Dec;17(3):477-84. doi: 10.1006/prep.1999.1155. Protein Expr Purif. 1999. PMID: 10600468
-
Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes.Arch Virol. 2006 Nov;151(11):2133-48. doi: 10.1007/s00705-006-0798-8. Epub 2006 Jun 22. Arch Virol. 2006. PMID: 16791442 Review.
-
Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.Vaccine. 2006 Aug 31;24 Suppl 3:S3/106-13. doi: 10.1016/j.vaccine.2006.05.110. Epub 2006 Jun 23. Vaccine. 2006. PMID: 16949996 Review.
Cited by
-
Genetic characterization of Sus scrofa papillomavirus type 1 from domestic pigs in Guangxi Province, China.Braz J Microbiol. 2023 Sep;54(3):2437-2443. doi: 10.1007/s42770-023-01092-1. Epub 2023 Aug 14. Braz J Microbiol. 2023. PMID: 37578737 Free PMC article.
-
Identification of a novel human gammapapillomavirus species.J Gen Virol. 2009 Oct;90(Pt 10):2413-2417. doi: 10.1099/vir.0.012344-0. Epub 2009 Jul 1. J Gen Virol. 2009. PMID: 19570953 Free PMC article.
-
Papillomaviral skin diseases of humans, dogs, cats and horses: A comparative review. Part 1: Papillomavirus biology and hyperplastic lesions.Vet J. 2022 Oct;288:105897. doi: 10.1016/j.tvjl.2022.105897. Epub 2022 Sep 20. Vet J. 2022. PMID: 36150643 Free PMC article. Review.
-
Ancient papillomavirus-host co-speciation in Felidae.Genome Biol. 2007;8(4):R57. doi: 10.1186/gb-2007-8-4-r57. Genome Biol. 2007. PMID: 17430578 Free PMC article.
-
Clinical and epidemiological aspects in equine aural plaques.Vet Res Commun. 2024 Nov 13;49(1):1. doi: 10.1007/s11259-024-10572-0. Vet Res Commun. 2024. PMID: 39535627
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources